ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

GABELLI FUNDS LLC's Holding History (CIK: 0001081407)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 2,000,000 Value ($000) $3,300 Avg Close — Range —
Q2 2025
Shares 2,500,000 Value ($000) $3,255 Avg Close — Range —
Q1 2025
Shares 2,500,000 Value ($000) $2,886 Avg Close — Range —